| Dr Ozlem A Belen, MD | |
|
644 Snow Goose Ln, Annapolis, MD 21409-5757 | |
| (443) 838-7345 | |
| (410) 757-9642 |
| Full Name | Dr Ozlem A Belen |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Pediatric Infectious Diseases |
| Location | 644 Snow Goose Ln, Annapolis, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972638674 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0208X | Pediatrics - Pediatric Infectious Diseases | D0052296 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ozlem A Belen, MD 644 Snow Goose Ln, Annapolis, MD 21409-5757 Ph: (443) 838-7345 | Dr Ozlem A Belen, MD 644 Snow Goose Ln, Annapolis, MD 21409-5757 Ph: (443) 838-7345 |
News Archive
Patients with advanced non-small cell lung cancer whose disease has progressed following chemotherapy have a higher rate of tumor shrinkage and a longer interval before cancer progression when bevacizumab is added to standard second-line erlotinib therapy, according to a study presented at the 2008 Chicago Multidisciplinary Symposium in Thoracic Oncology, sponsored by ASTRO, ASCO, IASLC and the University of Chicago.
A team of researchers, led by surgeons at the Kimmel Cancer Center at Jefferson in Philadelphia, has found further evidence supporting the ability of a protein to predict how well a patient with advanced pancreatic cancer will do after surgery, chemotherapy and radiation.
With HIV patients living longer thanks to advances in treatment, the primary care needs of those living with HIV have never been more important. Updated, evidence-based guidelines from the HIV Medicine Association (HIVMA) and the Infectious Diseases Society of America (IDSA) are designed to help providers manage the care of those living with this complex chronic infection.
K-PAX Pharmaceuticals is working with Stanford University and several other leading research institutions to perform a Phase II double-blind, placebo-controlled trial to evaluate the safety and efficacy of a currently available FDA-approved medication concurrently administered with a novel mitochondrial support product in order to identify a safe and effective treatment for the chronic fatigue and decreased alertness (i.e. brain fog) that commonly afflicts people with CFS.
Freezing of medical tissue and cells usually requires the addition of cryopreservatives, although the added compounds can have undesired effects in subsequent applications.
› Verified 6 days ago
John W Mcgrath, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 200 Forbes St, Annapolis, MD 21401 Phone: 410-263-6363 Fax: 410-263-4086 | |
Dr. Jeffrey T Nold, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 2024 West St Ste 400, Annapolis, MD 21401 Phone: 410-224-7667 Fax: 410-573-4926 | |
Dr. Gail Sue-ann Rose-green, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: Pm Pediatrics Of Annapolis, Festival At Riva Shopping Center, 2301-a Forest Drive, Annapolis, MD 21401 Phone: 410-266-6767 Fax: 410-266-6761 | |
Petra Vaclavkova, MD, PHD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2001 Medical Parkway, Annapolis, MD 21401 Phone: 443-481-1000 | |
Dr. Salwa Elsamanoudi, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2629 Riva Rd, Suite 112, Annapolis, MD 21401 Phone: 410-266-1000 Fax: 410-573-4028 | |
Dr. Suzanne Rindfleisch, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2001 Medical Pkwy, Annapolis, MD 21401 Phone: 443-481-6962 Fax: 443-481-6954 | |
Dr. Zwena Mcleod-o'donnell, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 200 Forbes St Ste 200, Annapolis, MD 21401 Phone: 410-263-6363 Fax: 410-263-7551 |